{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:58:01Z","timestamp":1786982281722,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:00:00Z","timestamp":1613174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan","award":["25461816"],"award-info":[{"award-number":["25461816"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12149-021-01575-x","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T08:42:49Z","timestamp":1613292169000},"page":"397-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Diagnostic performance of 68Ga-DOTATOC PET\/CT in tumor-induced osteomalacia"],"prefix":"10.1007","volume":"35","author":[{"given":"Ayako","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-8048","authenticated-orcid":false,"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Temma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Saga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,13]]},"reference":[{"key":"1575_CR1","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.humpath.2013.07.016","volume":"44","author":"M Houang","year":"2013","unstructured":"Houang M, Clarkson A, Sioson L, Elston MS, Clifton-Bligh RJ, Dray M, et al. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol. 2013;44:2711\u20138.","journal-title":"Hum Pathol"},{"key":"1575_CR2","first-page":"1922","volume":"56","author":"JC Reubi","year":"1996","unstructured":"Reubi JC, Waser B, Laissue JA, Gebbers JO. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res. 1996;56:1922\u201331.","journal-title":"Cancer Res"},{"key":"1575_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","volume":"359","author":"SM Jan-de-Beur","year":"2002","unstructured":"Jan-de-Beur SM, Streeten EA, Civelek AC, McCarthy EF, Uribe L, Marx SJ, et al. Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet. 2002;359:761\u20133.","journal-title":"Lancet"},{"key":"1575_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","volume":"24","author":"BD Nguyen","year":"1999","unstructured":"Nguyen BD, Wang EA. Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia. Clin Nucl Med. 1999;24:130\u20131.","journal-title":"Clin Nucl Med"},{"key":"1575_CR5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1210\/jc.2012-3642","volume":"98","author":"RJ Clifton-Bligh","year":"2013","unstructured":"Clifton-Bligh RJ, Hofman MS, Duncan E, Sim IW, Darnell D, Clarkson A, et al. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT. J Clin Endocrinol Metab. 2013;98:687\u201394.","journal-title":"J Clin Endocrinol Metab"},{"key":"1575_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","volume":"64","author":"S Breer","year":"2014","unstructured":"Breer S, Brunkhorst T, Beil FT, Peldschus K, Heiland M, Klutmann S, et al. 68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT. Bone. 2014;64:222\u20137.","journal-title":"Bone"},{"key":"1575_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cen.12426","volume":"81","author":"S Jadhav","year":"2014","unstructured":"Jadhav S, Kasaliwal R, Lele V, Rangarajan V, Chandra P, Shah H, et al. Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients. Clin Endocrinol (Oxf). 2014;81:31\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1575_CR8","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","volume":"40","author":"K Agrawal","year":"2015","unstructured":"Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, et al. Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med. 2015;40:e6\u201310.","journal-title":"Clin Nucl Med"},{"key":"1575_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","volume":"40","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhu Z, Zhong D, Dang Y, Xing H, Du Y, et al. 68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia. Clin Nucl Med. 2015;40:642\u20136.","journal-title":"Clin Nucl Med"},{"key":"1575_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s13139-015-0328-2","volume":"49","author":"CL Ho","year":"2015","unstructured":"Ho CL. Ga68-DOTA peptide PET\/CT to detect occult mesenchymal tumor-inducing osteomalacia: a case series of three patients. Nucl Med Mol Imaging. 2015;49:231\u20136.","journal-title":"Nucl Med Mol Imaging"},{"key":"1575_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cen.12822","volume":"84","author":"N Bhavani","year":"2016","unstructured":"Bhavani N, Reena Asirvatham A, Kallur K, Menon AS, Pavithran PV, Nair V, et al. Utility of Gallium-68 DOTANOC PET\/CT in the localization of tumour-induced osteomalacia. Clin Endocrinol (Oxf). 2016;84:134\u201340.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1575_CR12","doi-asserted-by":"publisher","first-page":"20160811","DOI":"10.1259\/bjr.20160811","volume":"90","author":"D Singh","year":"2017","unstructured":"Singh D, Chopra A, Ravina M, Kongara S, Bhatia E, Kumar N, et al. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET\/CT scan in identifying the culprit lesion and its management. Br J Radiol. 2017;90:20160811.","journal-title":"Br J Radiol"},{"key":"1575_CR13","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1210\/jc.2016-2052","volume":"101","author":"D El-Maouche","year":"2016","unstructured":"El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, et al. Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2016;101:3575\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"1575_CR14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/RLU.0000000000002290","volume":"43","author":"J Ding","year":"2018","unstructured":"Ding J, Hu G, Wang L, Li F, Huo L. Increased activity due to fractures does not significantly affect the accuracy of 68Ga-DOTATATE PET\/CT in the detection of culprit tumor in the evaluation of tumor-induced osteomalacia. Clin Nucl Med. 2018;43:880\u20136.","journal-title":"Clin Nucl Med"},{"key":"1575_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s13139-018-0546-5","volume":"52","author":"S Ha","year":"2018","unstructured":"Ha S, Park S, Kim H, Go H, Lee SH, Choi JY, et al. successful localization using 68Ga-DOTATOC PET\/CT of a phosphaturic mesenchymal tumor causing osteomalacia in a patient with concurrent follicular lymphoma. Nucl Med Mol Imaging. 2018;52:462\u20137.","journal-title":"Nucl Med Mol Imaging"},{"key":"1575_CR16","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s00270-016-1350-1","volume":"39","author":"M Maybody","year":"2016","unstructured":"Maybody M, Grewal RK, Healey JH, Antonescu CR, Fanchon L, Hwang S, et al. Ga-68 DOTATOC PET\/CT-guided biopsy and cryoablation with autoradiography of biopsy specimen for treatment of tumor-induced osteomalacia. Cardiovasc Intervent Radiol. 2016;39:1352\u20137.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1575_CR17","first-page":"20150497","volume":"2","author":"J Maehara","year":"2016","unstructured":"Maehara J, Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Matsumoto Y, et al. Primary phosphaturic mesenchymal tumour of the lumbar spine: utility of. BJR Case Rep. 2016;2:20150497.","journal-title":"BJR Case Rep"},{"key":"1575_CR18","doi-asserted-by":"crossref","unstructured":"Kawai S, Ariyasu H, Furukawa Y, Yamamoto R, Uraki S, Takeshima K, et al. Effective localization in tumor-induced osteomalacia using 68Ga-DOTATOC-PET\/CT, venous sampling and 3T-MRI. Endocrinol Diabetes Metab Case Rep. 2017;2017.","DOI":"10.1530\/EDM-17-0005"},{"key":"1575_CR19","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1007\/s00259-018-3971-x","volume":"45","author":"M Paquet","year":"2018","unstructured":"Paquet M, Gauth\u00e9 M, Zhang Yin J, Nataf V, B\u00e9lissant O, Orcel P, et al. Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET\/CT for detecting ostemoalacia-associated tumours. Eur J Nucl Med Mol Imaging. 2018;45:1710\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1575_CR20","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","volume":"42","author":"I Endo","year":"2008","unstructured":"Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, et al. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone. 2008;42:1235\u20139.","journal-title":"Bone"},{"key":"1575_CR21","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ejrad.2013.04.006","volume":"82","author":"H Jing","year":"2013","unstructured":"Jing H, Li F, Zhuang H, Wang Z, Tian J, Xing X, et al. Effective detection of the tumors causing osteomalacia using [Tc-99m]-HYNIC-octreotide (99mTc-HYNIC-TOC) whole body scan. Eur J Radiol. 2013;82:2028\u201334.","journal-title":"Eur J Radiol"},{"key":"1575_CR22","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2217\/fon.14.139","volume":"10","author":"CB Johnbeck","year":"2014","unstructured":"Johnbeck CB, Knigge U, Kj\u00e6r A. PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature. Future Oncol. 2014;10:2259\u201377.","journal-title":"Future Oncol"},{"key":"1575_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00223-010-9369-9","volume":"86","author":"A Ishii","year":"2010","unstructured":"Ishii A, Imanishi Y, Kobayashi K, Hashimoto J, Ueda T, Miyauchi A, et al. The levels of somatostatin receptors in causative tumors of oncogenic osteomalacia are insufficient for their agonist to normalize serum phosphate levels. Calcif Tissue Int. 2010;86:455\u201362.","journal-title":"Calcif Tissue Int"},{"key":"1575_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s002560000306","volume":"30","author":"A Ogose","year":"2001","unstructured":"Ogose A, Hotta T, Emura I, Hatano H, Inoue Y, Umezu H, et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skeletal Radiol. 2001;30:99\u2013103.","journal-title":"Skeletal Radiol"},{"key":"1575_CR25","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.humpath.2013.04.027","volume":"44","author":"K Uchihashi","year":"2013","unstructured":"Uchihashi K, Nishijima-Matsunobu A, Matsuyama A, Yamasaki F, Tanabe T, Uemura T, et al. Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis. Hum Pathol. 2013;44:2614\u20138.","journal-title":"Hum Pathol"},{"key":"1575_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3892\/ol.2014.2081","volume":"8","author":"T Morimoto","year":"2014","unstructured":"Morimoto T, Takenaka S, Hashimoto N, Araki N, Myoui A, Yoshikawa H. Malignant phosphaturic mesenchymal tumor of the pelvis: a report of two cases. Oncol Lett. 2014;8:67\u201371.","journal-title":"Oncol Lett"},{"key":"1575_CR27","doi-asserted-by":"publisher","first-page":"e6750","DOI":"10.1097\/MD.0000000000006750","volume":"96","author":"S Qiu","year":"2017","unstructured":"Qiu S, Cao LL, Qiu Y, Yan P, Li ZX, Du J, et al. Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: a case report. Medicine (Baltimore). 2017;96:e6750.","journal-title":"Medicine (Baltimore)"},{"key":"1575_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28:1\u201330.","journal-title":"Am J Surg Pathol"},{"key":"1575_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2967\/jnmt.116.177873","volume":"44","author":"S Basu","year":"2016","unstructured":"Basu S, Fargose P. 177Lu-DOTATATE PRRT in recurrent skull\u2013base phosphaturic mesenchymal tumor causing osteomalacia: a potential application of PRRT beyond neuroendocrine tumors. J Nucl Med Technol. 2016;44:248\u201350.","journal-title":"J Nucl Med Technol"},{"key":"1575_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1210\/js.2016-1088","volume":"1","author":"A Nair","year":"2017","unstructured":"Nair A, Chakraborty S, Dharmshaktu P, Tandon N, Gupta Y, Khadgawat R, et al. Peptide receptor radionuclide and octreotide: a novel approach for metastatic tumor-induced osteomalacia. J Endocr Soc. 2017;1:726\u201330.","journal-title":"J Endocr Soc"},{"key":"1575_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00000441-199507000-00011","volume":"310","author":"JL Shaker","year":"1995","unstructured":"Shaker JL, Brickner RC, Divgi AB, Raff H, Findling JW. Case report: renal phosphate wasting, syndrome of inappropriate antidiuretic hormone, and ectopic corticotropin production in small cell carcinoma. Am J Med Sci. 1995;310:38\u201341.","journal-title":"Am J Med Sci"},{"key":"1575_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1066896915617828","volume":"24","author":"A Sauder","year":"2016","unstructured":"Sauder A, Wiernek S, Dai X, Pereira R, Yudd M, Patel C, et al. FGF23-associated tumor-induced osteomalacia in a patient with small cell carcinoma: a case report and regulatory mechanism study. Int J Surg Pathol. 2016;24:116\u201320.","journal-title":"Int J Surg Pathol"},{"key":"1575_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bone.2012.11.040","volume":"53","author":"P Chiam","year":"2013","unstructured":"Chiam P, Tan HC, Bee YM, Chandran M. Oncogenic osteomalacia \u2013 hypophosphataemic spectrum from \u201cbenignancy\u201d to \u201cmalignancy.\u201d Bone. 2013;53:182\u20137.","journal-title":"Bone"},{"key":"1575_CR34","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00520-012-1474-z","volume":"20","author":"MP Mak","year":"2012","unstructured":"Mak MP, da Costa e Silva VT, Martin RM, Lerario AM, Yu L, Hoff PM, et al. Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition. Support Care Cancer. 2012;20:2195\u20137.","journal-title":"Support Care Cancer."},{"key":"1575_CR35","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1210\/jc.2012-3473","volume":"98","author":"DE Leaf","year":"2013","unstructured":"Leaf DE, Pereira RC, Bazari H, J\u00fcppner H. Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma. J Clin Endocrinol Metab. 2013;98:887\u201391.","journal-title":"J Clin Endocrinol Metab"},{"key":"1575_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bonr.2015.11.004","volume":"5","author":"EG Abate","year":"2016","unstructured":"Abate EG, Bernet V, Cortese C, Garner HW. Tumor induced osteomalacia secondary to anaplastic thyroid carcinoma: a case report and review of the literature. Bone Rep. 2016;5:81\u20135.","journal-title":"Bone Rep"},{"key":"1575_CR37","first-page":"411","volume":"45","author":"CE Dent","year":"1976","unstructured":"Dent CE, Gertner JM. Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med. 1976;45:411\u201320.","journal-title":"Q J Med"},{"key":"1575_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112:683\u201392.","journal-title":"J Clin Invest"},{"key":"1575_CR39","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","volume":"78","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Koshiyama H, Miyauchi A, Wakasa K, Kawata T, et al. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci. 2006;78:2295\u2013301.","journal-title":"Life Sci"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01575-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-021-01575-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01575-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T10:27:18Z","timestamp":1614076038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-021-01575-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,13]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1007\/s12149-021-01575-x","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,13]]},"assertion":[{"value":"30 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}